EP3248600B8 — Combinations and modes of administration of therapeutic agents and combination therapy
Assigned to Abraxis Bioscience LLC · Expires 2020-06-24 · 6y expired
What this patent protects
Provided herein is a composition comprising nanoparticles comprising paclitaxel and an albumin for use in a method for the treatment of cancer in an individual, wherein the method further comprises administering an antimetabolite.
USPTO Abstract
Provided herein is a composition comprising nanoparticles comprising paclitaxel and an albumin for use in a method for the treatment of cancer in an individual, wherein the method further comprises administering an antimetabolite.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.